An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19
Clinical trial NCT04412018 · COMPLETED
Trial details
- NCT number
- NCT04412018
- Sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2020-11-06
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.